Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 16.85
+0.20 (1.20%)
At close: Aug 27, 2026
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €126.65 million as of August 27, 2026. Its market cap has increased by 178.23% in one year.
Market Cap
126.65M
Enterprise Value
124.45M
Revenue
9.69M
Ranking
n/a
PE Ratio
43.72
Stock Price
€16.85
ChartMarket Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 126.65M, an increase of 724.10%. That is a compound annual growth rate of 60.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 126.65M | 96.87% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.03B |
| Laboratorios Farmaceuticos Rovi | 3.06B |
| Almirall | 2.24B |
| Pharma Mar | 1.43B |
| Clínica Baviera | 942.75M |
| Oryzon Genomics | 232.45M |
| Prim, S.A. | 227.06M |
| Laboratorio Reig Jofre | 217.37M |